Patterns of Statin Initiation, Intensification, and Maximization Among Patients Hospitalized With an Acute Myocardial Infarction

被引:71
作者
Arnold, Suzanne V. [1 ]
Kosiborod, Mikhail [1 ]
Tang, Fengming [1 ]
Zhao, Zhenxiang [2 ]
Maddox, Thomas M. [3 ]
McCollam, Patrick L. [2 ]
Birt, Julie [2 ]
Spertus, John A. [1 ]
机构
[1] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Eastern Colorado Hlth Care Syst, Denver, CO USA
基金
美国国家卫生研究院;
关键词
lipids; myocardial infarction; secondary prevention; statins; HMG-CoA; ACUTE CORONARY SYNDROME; ASSOCIATION TASK-FORCE; LIPID-LOWERING THERAPY; CARDIOVASCULAR ANGIOGRAPHY; PULMONARY REHABILITATION; AMERICAN ASSOCIATION; EMERGENCY PHYSICIANS; WRITING COMMITTEE; ST-ELEVATION; METAANALYSIS;
D O I
10.1161/CIRCULATIONAHA.113.003589
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background Intensive statins are superior to moderate statins in reducing morbidity and mortality after an acute myocardial infarction. Although studies have documented rates of statin prescription as a quality performance measure, variations in hospitals' rates of initiating, intensifying, and maximizing statin therapy after acute myocardial infarction are unknown. Methods and Results We assessed statin use at admission and discharge among 4340 acute myocardial infarction patients from 24 US hospitals (2005-2008). Hierarchical models estimated site variation in statin initiation in naive patients, intensification in those undergoing submaximal therapy, and discharge on maximal therapy (defined as a statin with expected low-density lipoprotein cholesterol lowering 50%) after adjustment for patient factors, including low-density lipoprotein cholesterol level. Site variation was explored with a median rate ratio, which estimates the relative difference in risk ratios of 2 hypothetically identical patients at 2 different hospitals. Among statin-naive patients, 87% without a contraindication were prescribed a statin, with no variability across sites (median rate ratio, 1.02). Among patients who arrived on submaximal statins, 26% had their statin therapy intensified, with modest site variability (median rate ratio, 1.47). Among all patients without a contraindication, 23% were discharged on maximal statin therapy, with substantial hospital variability (median rate ratio, 2.79). Conclusions In a large, multicenter acute myocardial infarction cohort, statin therapy was begun in nearly 90% of patients during hospitalization, with no variability across sites; however, rates of statin intensification and maximization were low and varied substantially across hospitals. Given that more intense statin therapy is associated with better outcomes, changing the existing performance measures to include the intensity of statin therapy may improve care.
引用
收藏
页码:1303 / 1309
页数:7
相关论文
共 19 条
[1]
ACC/AHA 2007 Guidelines for the Management of Patients With unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine [J].
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Antman, Elliott M. ;
Bridges, Charles R. ;
Califf, Robert M. ;
Casey, Donald E., Jr. ;
Chavey, William E. ;
Fesmire, Francis M. ;
Hochman, Judith S. ;
Levin, Thomas N. ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Theroux, Pierre ;
Wenger, Nanette Kass ;
Wright, R. Scott ;
Smith, Sidney C. ;
Jacobs, Alice K. ;
Halperin, Jonathan L. ;
Hunt, Sharon A. ;
Krumholz, Harlan M. ;
Kushner, Frederick G. ;
Lytle, Bruce W. ;
Nishimura, Rick ;
Ornato, Joseph P. ;
Page, Richard L. ;
Riegel, Barbara .
CIRCULATION, 2007, 116 (07) :E148-E304
[2]
Statin Use in Outpatients With Obstructive Coronary Artery Disease [J].
Arnold, Suzanne V. ;
Spertus, John A. ;
Tang, Fengming ;
Krumholz, Harlan M. ;
Borden, William B. ;
Farmer, Steven A. ;
Ting, Henry H. ;
Chan, Paul S. .
CIRCULATION, 2011, 124 (22) :2405-+
[3]
Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) Design and Rationale of a Prospective Multicenter Registry [J].
Arnold, Suzanne V. ;
Chan, Paul S. ;
Jones, Philip G. ;
Decker, Carole ;
Buchanan, Donna M. ;
Krumholz, Harlan M. ;
Ho, P. Michael ;
Spertus, John A. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (04) :467-476
[4]
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[5]
Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[6]
Low-Density Lipoprotein Cholesterol Level in Patients With Acute Myocardial Infarction Having Percutaneous Coronary Intervention (the Cholesterol Paradox) [J].
Cho, Kyung Hoon ;
Jeong, Myung Ho ;
Ahn, Youngkeun ;
Kim, Young Jo ;
Chae, Shung Chull ;
Hong, Taek Jong ;
Seong, In Whan ;
Chae, Jei Keon ;
Kim, Chong Jin ;
Cho, Myeong Chan ;
Seung, Ki Bae ;
Park, Seung Jung .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (08) :1061-1068
[7]
Lack of therapeutic interchangeability of HMG-CoA reductase inhibitors [J].
Chong, PH .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (12) :1907-1917
[8]
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[9]
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial [J].
de Lemos, JA ;
Blazing, MA ;
Wiviott, SD ;
Lewis, EF ;
Fox, KAA ;
White, HD ;
Rouleau, JL ;
Pedersen, TR ;
Gardner, LH ;
Mukherjee, R ;
Ramsey, KE ;
Palmisano, J ;
Bilheimer, DW ;
Pfeffer, MA ;
Califf, RM ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1307-1316
[10]
Impact of medication therapy discontinuation on mortality after myocardial infarction [J].
Ho, P. Michael ;
Spertus, John A. ;
Masoudi, Frederick A. ;
Reid, Kimberly J. ;
Peterson, Eric D. ;
Magid, David J. ;
Krumholz, Harlan M. ;
Rumsfeld, John S. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (17) :1842-1847